According to Glonghui on July 15, Hang Seng Index launched the Hang Seng A-share Entrepreneurship Index, which tracks the overall performance of the 50 A-shares with the largest market capitalization listed on the GEM board of the Shenzhen Stock Exchange.
This index provides a reference for investors interested in investing in Shenzhen GEM to capture the potential growth of innovative businesses and emerging industries.
Currently, the three business categories with the highest share of the index are healthcare, industrial engineering and software services, which together account for more than 60% of the constituent stocks.
Looking at the specific situation, the selection criteria for this index are relatively simple, including:
A-share companies listed on the Shenzhen Stock Exchange GEM;
The listing period is at least 6 months;
The top 50 companies were selected as constituent stocks based on the average market capitalization ranking of the last 6 months.
The index was launched on July 15, 2019. The base date is September 3, 2010 as the standard, and the base value is 3,000 points.
The review cycle is every six months. The weighting method is calculated according to the current market capitalization weighting method. The maximum weight of each constituent stock is 10%. The index is immediately released every 2 seconds, and #收市指数提供美元、人民币及港币计算数值作为参考。
![image.png](https://img3.gelonghui.com/201907/p20190715173726443.png?x-oss-process=style/wm)
According to the information attached to the Hang Seng A-share Entrepreneurship Index, as of July 12, 2019, the 10 constituent stocks with the highest share of the index include Wen's shares (300498.SZ), Oriental Wealth (300059.SZ), Aier Ophthalmology (300015.SZ), Watson Biotech (300142.SZ), Mindray Healthcare, etc. The top three with the most weight were Wen's shares, Oriental Wealth, and Aier Ophthalmology, respectively.
Furthermore, according to the index's guidelines, the consumer goods manufacturing industry, IT industry and industrial sector accounted for a relatively large share of constituent stocks as of July 12, 2019, at 36.54%, 24.45%, and 20.85%, respectively.
Among them,In the consumer goods manufacturing industry, the healthcare industry accounts for a large share.Mainly because there are currently 11 medical and pharmaceutical companies listed on this list, especially inOf the top ten major constituent stocks, as many as half are in the medical and pharmaceutical industry.These include Aier Ophthalmology, Watson Biotech, Mindray Biotech, Lepu Healthcare, and Zhifei Biotech. In addition, there are agricultural products, home appliances, and 1 food and drink company each under this sector.
In the executive technology sector, a total of 12 companies are on the list, including 9 software service companies, 2 executive technology equipment companies, and 1 semiconductor company.
According to industry insiders, in the A-share market, indices that track GEM are actually not uncommon. They mainly include strategic or industry passive indices. These indices have many meanings. They can not only analyze the specific performance of the GEM market, but also provide them with some reference guidelines for identifying industry trends and investment decisions. Therefore,Now, more and more investors are beginning to like to invest in relevant index tracking funds, or use them as reference stock selection strategies, so as to share the development dividends of some industries while avoiding the risk of falling behind due to careless stock selection due to personal ability to select stocks to the greatest extent.
However, as for the launch of the A-share Entrepreneurship Index for investors, market investors will use this as a reference for stock selection strategies. At the same time, whether related listings that are expected to be selected will be sought after by the market, and whether they will even usher in a wave of concept hype, which is worth looking forward to.
Attachment: List of the top 50 A-share companies by market value in GEM circulation (6 months after listing)